BioCentury
ARTICLE | Company News

Deltagen to phenotype Schering-Plough genes

February 16, 2000 8:00 AM UTC

Deltagen (Menlo Park, Calif.) will use its DeltaSelect mammalian gene knockout and phenotyping technology to define gene function in vivo of small molecule drug targets from Schering-Plough Research I...